SGLT2 Inhibitors Market Forecast 2030: Key Players & Emerging Trends
SGLT2 Inhibitors Market Size & Insights The Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.68% during the forecast period, i.e., 2025-30. The Global SGLT2 Inhibitor Industry is significantly growing due to several growth factors, including the rising burden of chronic disorders like type 2 diabetes, chronic kidney disorders, cardiovascular diseases, etc., the governmental support from different countries for the healthcare development & mass screening for these chronic disorders, the globally rising aging population, and the adoption of the next-generation SGLT2 inhibitors, and many more.
What are the Key DROs in the SGLT2 Inhibitors Market? High Prevalence of Chronic Diseases – The market demand is driven by the high burden of chronic disorders globally, especially cardiovascular diseases, chronic disorders, and type 2 diabetes. For instance, as per the International Diabetes Federation (2021), there were over 540 million adult patients with type 2 diabetes globally, which is further expected to reach more than 640 million. Similarly, chronic kidney disease (CKD) is also highly prevalent globally, accounting for more than 840 million individuals all around the world. Also, more than 65 million individuals experience heart failure globally.
What are the Key Segments in the SGLT2 Inhibitors Market? The SGLT2 Inhibitors is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:
By Drug Type
Jardiance (empagliflozin) SGLT2 Inhibitors Farxiga (dapagliflozin) SGLT2 Inhibitors Invokana (canagliflozin) SGLT2 Inhibitors Inpefa (sotagliflozin) SGLT2 Inhibitors Qtern (dapagliflozin/saxagliptin) SGLT2 Inhibitors OthersSGLT2 Inhibitors By Application
Type 2 DiabetesSGLT2 Inhibitors CardiovascularSGLT2 Inhibitors Chronic Kidney Disease (CKD) SGLT2 Inhibitors OthersSGLT2 Inhibitors Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/sglt2-inhibitors-market.html
By End User
Hospital PharmaciesSGLT2 Inhibitors Retail PharmaciesSGLT2 Inhibitors Online PharmaciesSGLT2 Inhibitors Out of these, Hospital Pharmacies are dominating the Global SGLT2 Inhibitors Industry with a market share of more than 60%.
How does geographical analysis highlight in the SGLT2 Inhibitors market? By Region
North America South America Europe The Middle East & Africa Asia-Pacific North America holds the largest market share of more than 42%.
Who are the Key Players in SGLT2 Inhibitors Market? Astellas AstraZeneca Boehringer Ingelheim International Bristol-Myers Squibb Company Eli Lilly and Company Glenmark Pharmaceuticals Johnson & Johnson (Janssen Pharmaceuticals) Lexicon Pharmaceuticals Lupin Limited Merck Sanofi TheracosBio and others. Browse Full Reports – https://www.marknteladvisors.com/research-library/sglt2-inhibitors-market.html
SGLT2 Inhibitors Market News 2024: Eli Lilly and Company launched a new combination therapy, bringing together its SGLT2 inhibitor Jardiance (empagliflozin) with a GLP-1 agonist. This new treatment helps improve blood sugar control and supports weight loss in people with type 2 diabetes, offering a more effective option for managing the condition. Key pillars of the research methodology include: Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets. Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations. Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias. Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations. “Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide,” said a spokesperson for MarkNtel Advisors.
Other reports: Evaluating the Significantly Growing Ovarian Cancer Market
How Lucrative is the Future of the Li-Fi Market?
Why This MarkNtel Advisors Research Report: In-depth Market Analysis: Understand trends and dynamics shaping growth. Segmented Insights: Target specific segments for focused strategies. Geographical Performance: Assess market opportunities by geographic area. Emerging Technologies: Discover advancements like AI integration. Risk Identification: Pinpoint challenges to inform strategic planning. Future Forecasts: Prepare for market changes with actionable projections. Gain exclusive access to our comprehensive insights on the Future of SGLT2 Inhibitors Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.
Select a License That Matches Your Business Requirements with Instant Offer – https://www.marknteladvisors.com/pricing/sglt2-inhibitors-market.html
Our Trusted Experts Are Here to Help:
At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.
Reach Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
Visit our Website: https://www.marknteladvisors.com
We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.